A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)

NCT01090167 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: clofarabine

Sponsor

Genzyme, a Sanofi Company